CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH is a premier journal published by Elsevier, dedicated to advancing the fields of cell biology and molecular biology. Established in 1982, this influential journal has been at the forefront of scientific research and innovation, currently holding esteemed positions with a Q2 ranking in Cell Biology and a Q1 ranking in Molecular Biology for 2023, reflecting its commitment to high-quality scholarship. With an impressive impact factor, it ranks in the 82nd and 78th percentiles for Molecular Biology and Cell Biology, respectively, amongst its peers. Researchers, professionals, and students will find this journal to be an invaluable resource for exploring the latest discoveries and methodologies in the molecular mechanisms underlying cellular functions. Although it is not an open-access journal, the insights offered in its pages contribute significantly to the scientific community's understanding of cellular and molecular processes, ensuring it remains a vital platform for disseminating cutting-edge research.

DEVELOPMENT GROWTH & DIFFERENTIATION, published by Wiley, stands as a vital journal in the realms of Cell Biology, Developmental Biology, and Medicine. With an ISSN of 0012-1592 and E-ISSN of 1440-169X, this esteemed journal has been a key player in the scientific community since its inception in 1969, continuing to contribute significantly to the understanding of developmental processes and mechanisms underlying growth and differentiation. Ranked Q3 in Cell Biology and Developmental Biology, and Q2 in miscellaneous aspects of Medicine as of 2023, the journal provides a platform for high-quality research articles, reviews, and critical insights that foster academic discourse in these vital fields. Although currently not available as open access, the journal ensures the availability of essential research to its global readership, facilitating collaboration and innovation. Researchers, professionals, and students alike will find DEVELOPMENT GROWTH & DIFFERENTIATION to be an invaluable resource for advancing knowledge and driving forward the scientific inquiry into the intricacies of biological development.

BIOLOGICAL PROCEDURES ONLINE is a premier open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. With its electronic ISSN 1480-9222 and a strong commitment to accessibility since 2009, this journal provides a vital platform for researchers and scholars to disseminate their findings and foster collaboration within the scientific community. Based in the United Kingdom, this journal has garnered an impressive reputation, achieving Q1 status in the 2023 category rankings, with notable inclusion in the Scopus rankings, placing it in the 86th percentile among 221 peer journals in the general biochemistry, genetics, and molecular biology domain. It covers a broad range of topics, ensuring coverage of the latest advancements and methodologies in biological procedures, making it an essential resource for academics, practitioners, and students alike. Researchers are encouraged to submit their innovative work and contribute to the ongoing dialogue in this dynamic and ever-evolving field.

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

Epigenetics, published by Taylor & Francis Inc, is a leading journal in the fields of Cancer Research, Medicine (miscellaneous), and Molecular Biology. With an ISSN of 1559-2294 and an E-ISSN of 1559-2308, this journal has been paving the way for groundbreaking research since its inception in 2006, and it continues to play a crucial role in advancing our understanding of epigenetic mechanisms and their implications in health and disease. The journal is highly regarded, ranking in the Q1 category for Medicine and Q2 for both Cancer Research and Molecular Biology according to the 2023 category quartiles. Researchers and professionals in the field will find invaluable insights and innovative studies within its pages, making it an essential resource for those engaged in cutting-edge research. Although the journal is not open access, it encourages a comprehensive understanding through high-quality peer-reviewed content. With its creative exploration of the epigenetic landscape, Epigenetics serves as a vital platform for the sharing of knowledge that could lead to breakthroughs in treatments and therapies.

GENES TO CELLS is a distinguished peer-reviewed journal published by Wiley, offering valuable insights into the intricate world of cell biology and genetics. With an ISSN of 1356-9597 and an E-ISSN of 1365-2443, this journal has been contributing to the academic community since its inception in 1996 and will continue its publishing journey until 2024. Recognized with a category quartile ranking of Q3 in both Cell Biology and Genetics, and Q2 in Medicine (Miscellaneous) as of 2023, it serves as an important platform for disseminating innovative research and reviews in molecular biology and related fields. Although it does not currently offer open access, the journal caters to a diverse readership by providing comprehensive studies that are essential for professionals, researchers, and students aiming to deepen their understanding of genetic mechanisms and cellular functions. Situated in the United Kingdom, GENES TO CELLS continues to play a pivotal role in shaping the future of biological research.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.